The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms.
暂无分享,去创建一个
C. Ghelardini | L. Posa | L. Micheli | L. di Cesare Mannelli | F. Caputi | P. Romualdi | S. Candeletti | L. Rullo | S. Stamatakos